Holen Sie sich die Stockscreener-App
275.43
0.90%
2.47
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$272.96
Offen:
$273.185
24-Stunden-Volumen:
1.95M
Relative Volume:
0.76
Marktkapitalisierung:
$105.65B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
31.90
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
+1.13%
1M Leistung:
-11.77%
6M Leistung:
-16.92%
1J Leistung:
-24.83%
1-Tages-Spanne:
$271.21
$276.97
1-Wochen-Bereich:
$271.10
$280.17
52-Wochen-Spanne:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp.SYK - PR Newswire
TD Cowen cuts target for Stryker stock from USD 355.00 to USD 298.00 - AD HOC NEWS
Stryker to announce third quarter 2026 financial results - Yahoo! Finance Canada
CEUX:SYKd Dividend: Does Stryker Corp Pay a Dividend? - GuruFocus
Stryker Price Target Cut to $330.00/Share From $360.00 by Stifel - Moomoo
Stryker (CEUX:SYKD) Graham Number : €N/A (As of Jun. 2026) - GuruFocus
Insiders At Stryker Sold US$582m In Stock, Alluding To Potential Weakness - Moomoo
Stryker stock faces analyst cuts as Stifel lowers target - AD HOC NEWS
Stifel cuts Stryker stock price target on revenue pressures - Investing.com
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker stock gains 1.77 percent as quarterly growth holds - AD HOC NEWS
Form 4 Stryker Corporation For: 28 September By Investing.com - Investing.com Canada
A 109-share employee stock plan transfer leaves Stryker (SYK) CFO holding 3,661 shares directly. - Stock Titan
Stryker Corp Lobbyists, 2021 - OpenSecrets
Is ResMed A Better Way Than Stryker To Own Medical Device Growth? - Yahoo Finance
Realty Income, Stryker and more dividends 2026 • Vienna Stock Exchange - Wiener Börse
Stryker stock trades at USD 270.92, down 0.91 percent in New York trading - AD HOC NEWS
ELFA Names James Cress Acting President & CEO - GlobeNewswire Inc.
Stryker Corp (CEUX:SYKd) Stock Price, Trades & News - GuruFocus
Form 4 Stryker Corporation For: 25 September By Investing.com - Investing.com Canada
Envestnet Asset Management Inc. Purchases 70,634 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock slips 1.2 percent ahead of the open - AD HOC NEWS
Stryker Corporation (SYK) Options ChainYahoo Finance - ca.finance.yahoo.com
Stryker faces investigation after CEO reveals o... - Pluang
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Under a matrimonial settlement, Stryker (SYK) CFO Wells Preston Wendell transferred shares twice. - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Stryker Corporation (SYK) And Encourages Shareholders to Connect - ACCESS Newswire
What Does General Dynamics (GD) Winning New Stryker Work Mean Through 2028? - Yahoo Finance
QRG Capital Management Inc. Decreases Holdings in Stryker Corporation $SYK - MarketBeat
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - theglobeandmail.com
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - Yahoo Finance
Stryker stock steadies after target cuts and earnings gains - AD HOC NEWS
Stryker stock heads into the open after a 0.33 percent gain - AD HOC NEWS
Stryker stock falls 21.6 percent as TD Cowen cuts target - AD HOC NEWS
Stryker Corporation $SYK Shares Bought by State Street Corp - MarketBeat
Stryker (SYK) Foot And Ankle Push Keeps Undervalued Narrative In Focus - Yahoo Finance
TD Cowen Maintains Stryker Corp(SYK.US) With Hold Rating, Cuts Target Price to $298 - Moomoo
Stryker (SYK) Expanded Its Foot And Ankle Portfolio - Yahoo Finance
TD Cowen cuts Stryker stock price target to $298 on margin concerns - Investing.com
Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating - marketscreener.com
Stryker stock before the bell after a 0.36 percent drop - AD HOC NEWS
Stryker (SYK): The Healthcare Stocks Name Everyone's Asking About - Kalkine Media
Stryker stock gains from Raymond James support - AD HOC NEWS
Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating - Yahoo Finance
Stryker Corp. stock heads into the open without fresh session data - AD HOC NEWS
Stryker Corp. stock holds steady amid lack of fresh data - AD HOC NEWS
Stryker Corp. stock underperforms Friday when compared to competitors - marketwatch.com
Securities firm investigates Stryker for possib... - Pluang
Stryker (NYSE:SYK) Given New $385.00 Price Target at Canaccord Genuity Group - MarketBeat
Stryker Is Maintained at Buy by Canaccord Genuity - Moomoo
Nykredit A S Purchases Shares of 282,407 Stryker Corporation $SYK - marketbeat.com
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stryker Corp-Aktie (SYK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Aug 18 '26 |
Sale |
335.90 |
300,000 |
100,770,963 |
2,301,375 |
| STRYKER RONDA E | Director |
Aug 19 '26 |
Sale |
340.10 |
50,000 |
17,005,165 |
2,251,375 |
| King Debra | See Remarks |
Aug 18 '26 |
Sale |
336.30 |
826 |
277,787 |
6,210 |
0.07%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):